A Conserved MicroRNAs Motif Reveals TDP ‐43 Pathology and MAPK Pathway Activation in Parkinson's Disease
The FASEB Journal · 2025
DOI: 10.1096/fj.202502382rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Mingyue Luan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Peking University First Hospital, Beijing, China. Hauptthemen laut MEDLINE: MAP Kinase Signaling System, MicroRNAs, Parkinson Disease. Die Arbeit nennt 40 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), STI2030-Major Projects, Beijing Nova Program.
Abstract (Originalsprache)
Parkinson's disease (PD), the second most common neurodegenerative disorder, involves dopaminergic neuron loss and α‐synuclein (α‐syn) aggregation. Recent studies have shown that dysregulation of microRNAs (miRNAs) is associated with PD, but little is known about its pathological mechanism. Here, we identified a conserved 5‐nucleotide motif (HBCCC; H = U, A, or C; B = U, C, or G) in 52 downregulated miRNAs from the salivary RT‐QuIC (real‐time quaking‐induced conversion)‐positive PD patients, accounting for 82.5% of these dysregulated miRNAs. The motif‐containing miRNAs, including miRNA‐6812‐3p and miRNA‐6848‐3p, were also significantly downregulated in the substantia nigra of PD patients. Quantitative Real‐Time PCR (RT‐qPCR), miRNA pull‐down assay, and western blot confirmed that TAR DNA binding protein‐43 (TDP‐43) bound to the motif‐containing miRNAs in vitro and was responsible for the biogenesis of these miRNAs. Furthermore, we found that TDP‐43 co‐aggregated with α‐syn in vitro and in vivo, which could be responsible for the downregulation of miRNAs. Motif‐containing miRNAs targeted the mitogen‐activated protein kinase (MAPK) pathway, and their downregulation in PD activated this pathway, as revealed by bioinformatic analysis. Interfering with MAPK expression alleviated movement disorders in a Drosophila PD model. These findings provide a potential therapeutic target for PD and highlight the pathological role of miRNAs in neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Peking University First Hospital, Beijing, China.
- Department of Human Anatomy, Histology and Embryology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine Peking Union Medical College, Beijing, China.
- State Key Laboratory of Brain and Cognitive Science, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
- Beijing Key Laboratory of Neurovascular Disease Discovery, Beijing, China.
- Key Laboratory for Neuroscience, Ministry of Education/National Health Commission, Peking University, Beijing, China.
ORCID-Profile: Jianwen Deng
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- STI2030-Major Projects
- Beijing Nova Program
- National High Level Hospital Clinical Research Funding (High Quality Clinical Research Project of Peking University First Hospital)
- National High Level Hospital Clinical Research Funding (Scientific and Technological Achievements Transformation Incubation Guidance Fund Project of Peking Uni…
- National Natural Science Foundation of China
Zitieren
APA
Luan, M., Wu, W., Zheng, F., Sun, Y., Wei, L., Li, F., Li, K., Chen, J., Sun, W., Zhu, L., Wang, Z., & Deng, J. (2025). A Conserved MicroRNAs Motif Reveals TDP ‐43 Pathology and MAPK Pathway Activation in Parkinson's Disease. The FASEB Journal. https://doi.org/10.1096/fj.202502382rr
Vancouver
Luan M, Wu W, Zheng F, Sun Y, Wei L, Li F, et al. A Conserved MicroRNAs Motif Reveals TDP ‐43 Pathology and MAPK Pathway Activation in Parkinson's Disease. The FASEB Journal. 2025. doi:10.1096/fj.202502382rr
BibTeX
@article{Luan2025,
author = {Luan, Mingyue and Wu, Wei and Zheng, Fuze and Sun, Yunchuang and Wei, Luhua and Li, Fan and Li, Kai and Chen, Jing and Sun, Wei and Zhu, Li and Wang, Zhaoxia and Deng, Jianwen},
title = {A Conserved MicroRNAs Motif Reveals TDP ‐43 Pathology and MAPK Pathway Activation in Parkinson's Disease},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202502382rr}
}
EUVIMED